Literature DB >> 17881563

Sustained antigen presentation can promote an immunogenic T cell response, like dendritic cell activation.

Reinhard Obst1, Hisse-Martien van Santen, Rachel Melamed, Alice O Kamphorst, Christophe Benoist, Diane Mathis.   

Abstract

Activation of dendritic cells (DCs) enhances their ability to prime naïve T cells. How activation renders them immunogenic rather than tolerogenic is unclear. Here, we show, using temporally regulated expression of a transgene-encoded neoself antigen in DCs, that either prolonged antigen presentation or DC activation could elicit full expansion, effector cytokine production, and memory-cell differentiation. Microarray analysis of gene expression in T cells showed that all changes linked to DC activation through CD40 could be reproduced by persistent antigen delivery, suggesting that stabilization of antigen presentation is an important consequence of DC activation in vivo. In this system, DC activation by CD40 engagement indeed extended their ability to present antigen to CD4(+) T cells in vivo, although different results were obtained with antigen delivered to DCs by means of endocytosis from the cell surface. These results suggest that antigen persistence may be an important discriminator of immunogenic and tolerogenic antigen exposure.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17881563      PMCID: PMC2000557          DOI: 10.1073/pnas.0707331104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate.

Authors:  Lélia Delamarre; Margit Pack; Henry Chang; Ira Mellman; E Sergio Trombetta
Journal:  Science       Date:  2005-03-11       Impact factor: 47.728

2.  Stable T cell-dendritic cell interactions precede the development of both tolerance and immunity in vivo.

Authors:  Guy Shakhar; Randall L Lindquist; Dimitris Skokos; Diana Dudziak; Julie H Huang; Michel C Nussenzweig; Michael L Dustin
Journal:  Nat Immunol       Date:  2005-05-29       Impact factor: 25.606

3.  The effect of paraffin oil and mycobacteria on antibody formation and sensitization; a review.

Authors:  J FREUND
Journal:  Am J Clin Pathol       Date:  1951-07       Impact factor: 2.493

4.  The duration of antigenic stimulation determines the fate of naive and effector T cells.

Authors:  G Iezzi; K Karjalainen; A Lanzavecchia
Journal:  Immunity       Date:  1998-01       Impact factor: 31.745

5.  Developmental regulation of MHC class II transport in mouse dendritic cells.

Authors:  P Pierre; S J Turley; E Gatti; M Hull; J Meltzer; A Mirza; K Inaba; R M Steinman; I Mellman
Journal:  Nature       Date:  1997-08-21       Impact factor: 49.962

6.  Selective development of CD4+ T cells in transgenic mice expressing a class II MHC-restricted antigen receptor.

Authors:  J Kaye; M L Hsu; M E Sauron; S C Jameson; N R Gascoigne; S M Hedrick
Journal:  Nature       Date:  1989-10-26       Impact factor: 49.962

Review 7.  Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity.

Authors:  Christian Münz; Ralph M Steinman; Shin-ichiro Fujii
Journal:  J Exp Med       Date:  2005-07-18       Impact factor: 14.307

8.  Number of T reg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells.

Authors:  Hisse-Martien van Santen; Christophe Benoist; Diane Mathis
Journal:  J Exp Med       Date:  2004-11-08       Impact factor: 14.307

9.  Antigen persistence is required throughout the expansion phase of a CD4(+) T cell response.

Authors:  Reinhard Obst; Hisse-Martien van Santen; Diane Mathis; Christophe Benoist
Journal:  J Exp Med       Date:  2005-05-16       Impact factor: 14.307

10.  Sustained signaling leading to T cell activation results from prolonged T cell receptor occupancy. Role of T cell actin cytoskeleton.

Authors:  S Valitutti; M Dessing; K Aktories; H Gallati; A Lanzavecchia
Journal:  J Exp Med       Date:  1995-02-01       Impact factor: 14.307

View more
  32 in total

Review 1.  Regulation of CD4 T-cell receptor diversity by vaccine adjuvants.

Authors:  Christina K Baumgartner; Laurent P Malherbe
Journal:  Immunology       Date:  2010-03-17       Impact factor: 7.397

2.  Role of antigen persistence and dose for CD4+ T-cell exhaustion and recovery.

Authors:  Shaobo Han; Ayuna Asoyan; Hannah Rabenstein; Naoko Nakano; Reinhard Obst
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-08       Impact factor: 11.205

3.  A simple mechanistic explanation for original antigenic sin and its alleviation by adjuvants.

Authors:  Wilfred Ndifon
Journal:  J R Soc Interface       Date:  2015-11-06       Impact factor: 4.118

4.  Differential response of regulatory and conventional CD4⁺ lymphocytes to CD3 engagement: clues to a possible mechanism of anti-CD3 action?

Authors:  Li Li; Junko Nishio; André van Maurik; Diane Mathis; Christophe Benoist
Journal:  J Immunol       Date:  2013-08-28       Impact factor: 5.422

5.  Dendritic cell migration limits the duration of CD8+ T-cell priming to peripheral viral antigen.

Authors:  Amanda M Schell; Erica L Granger; Frank Koczot; Matthew A Fischer; Christopher C Norbury
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

Review 6.  Early programming and late-acting checkpoints governing the development of CD4 T-cell memory.

Authors:  Kunal Dhume; Karl Kai McKinstry
Journal:  Immunology       Date:  2018-05-21       Impact factor: 7.397

7.  Preparation of Modified Konjac Glucomannan Nanoparticles and their Application as Vaccine Adjuvants to Promote Ovalbumin-Induced Immune Response in Mice.

Authors:  Na Chen; Pei Zhu; Ting Du; Kai Han; Dang Wang; Jianfeng Ye; Shaobo Xiao; Xiaozhou Ye; Yun Wang
Journal:  Pharm Res       Date:  2018-03-20       Impact factor: 4.200

8.  Nonintegrating lentivector vaccines stimulate prolonged T-cell and antibody responses and are effective in tumor therapy.

Authors:  Katarzyna Karwacz; Sayandip Mukherjee; Luis Apolonia; Michael P Blundell; Gerben Bouma; David Escors; Mary K Collins; Adrian J Thrasher
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

9.  Peptide-MHC class II complex stability governs CD4 T cell clonal selection.

Authors:  Christina K Baumgartner; Andrea Ferrante; Mika Nagaoka; Jack Gorski; Laurent P Malherbe
Journal:  J Immunol       Date:  2009-12-09       Impact factor: 5.422

10.  Nonreplicating vaccinia virus vectors expressing the H5 influenza virus hemagglutinin produced in modified Vero cells induce robust protection.

Authors:  Josef Mayrhofer; Sogue Coulibaly; Annett Hessel; Georg W Holzer; Michael Schwendinger; Peter Brühl; Marijan Gerencer; Brian A Crowe; Shen Shuo; Wanjing Hong; Yee Joo Tan; Barbara Dietrich; Nicolas Sabarth; Helga Savidis-Dacho; Otfried Kistner; P Noel Barrett; Falko G Falkner
Journal:  J Virol       Date:  2009-03-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.